dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Elez Fernandez, Mª Elena |
dc.contributor.author | Chianese, Chiara |
dc.contributor.author | Matito Ariza, Judit |
dc.contributor.author | Macarulla Mercadé, Teresa |
dc.contributor.author | Argilés Martinez, Guillem |
dc.contributor.author | Garcia Rodriguez, Ariadna |
dc.contributor.author | Mulet Margalef, Núria |
dc.contributor.author | Tabernero Caturla, Josep |
dc.contributor.author | Vivancos Prellezo, Ana |
dc.contributor.author | Sanz Garcia, Enrique |
dc.contributor.author | Martinelli, Erica |
dc.contributor.author | Noguerido Castro, Alba |
dc.contributor.author | Mancuso, Francesco Mattia |
dc.contributor.author | Caratù, Ginevra |
dc.contributor.author | Grasselli, Julieta |
dc.contributor.author | Martini, Giulia |
dc.contributor.author | Capdevila Castillon, Jaume |
dc.date.accessioned | 2020-01-30T08:40:37Z |
dc.date.available | 2020-01-30T08:40:37Z |
dc.date.issued | 2019-07-31 |
dc.identifier.citation | Elez E, Chianese C, Sanz‐García E, Martinelli E, Noguerido A, Mancuso FM, et al. Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS ‐mutant metastatic colorectal cancer. Mol Oncol. 2019;13(9):1827–35. |
dc.identifier.issn | 1574-7891 |
dc.identifier.uri | https://hdl.handle.net/11351/4572 |
dc.description | Càncer colorectal en metàstasi; Anàlisi RAS; Biomarcador com a pronòstic |
dc.description.sponsorship | This work was supported partially by the Instituto de Salud Carlos III (Ministerio de Economia y Competitividad) and `Fondo Europeo de Desarrollo Regional (FEDER), una manera de hacer Europa' grants [FIS PI12-01589 to RS] and RETICC Cancer. |
dc.language.iso | eng |
dc.publisher | FEBS Press |
dc.relation.ispartofseries | Molecular Oncology;13(9) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Metàstasi |
dc.subject | Citodiagnòstic |
dc.subject | Recte - Càncer - Prognosi |
dc.subject.mesh | Colorectal Neoplasms |
dc.subject.mesh | Neoplasm Staging |
dc.subject.mesh | Liquid Biopsy |
dc.subject.mesh | Neoplasm Metastasis |
dc.title | Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS‐mutant metastatic colorectal cancer |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1002/1878-0261.12547 |
dc.subject.decs | neoplasias colorrectales |
dc.subject.decs | biopsia líquida |
dc.subject.decs | estadificación de neoplasias |
dc.subject.decs | metástasis neoplásica |
dc.relation.publishversion | https://febs.onlinelibrary.wiley.com/doi/full/10.1002/1878-0261.12547 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.authoraffiliation | [Elez E, Sanz-García E, Noguerido A, Martini G, Macarulla T, Argilés G, Capdevila J, Garcia A, Tabernero J] Servei d’Oncologia Mèdica, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d'Hebron Institut d'Oncologia, Barcelona, Spain. [Chianese C, Mancuso FM, Caratù G, Matito J, Vivancos A] Grup de Genòmica del Càncer, Vall d'Hebron Institut d'Oncologia, Barcelona, Spain. [Martinelli E] Medical Oncology, Department of Clinical and Experimental Medicine ‘F. Magrassi’, Università della Campania ‘L. Vanvitelli’, Napoli, Italy. [Grasselli J] Servei d’Oncologia Mèdica, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Servei d’Oncologia Mèdica, Institut Català d’Oncologia, L'Hospitalet, Spain. Universitat de Barcelona, L'Hospitalet, Spain. [Mulet N] Servei d’Oncologia Mèdica, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d'Hebron Institut d'Oncologia, Barcelona, Spain. Servei d’Oncologia Mèdica, Institut Català d’Oncologia, L'Hospitalet, Spain. Universitat de Barcelona, L'Hospitalet, Spain. |
dc.identifier.pmid | 31322322 |
dc.identifier.wos | 000479553200001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |